Limiting Iranian Nuclear Activities

Options and Consequences

February 17, 2011

Report

Overview

How much Iranian nuclear capability is too much? The simplest answer is that any amount is unacceptable. But it is far from clear that zero enrichment is a realistic goal. To help illuminate other possibilities, Michael Levi investigates the differences between various possible states of the Iranian nuclear program.

Michael Levi
Michael Levi

David M. Rubenstein Senior Fellow for Energy and the Environment and Director of the Maurice R. Greenberg Center for Geoeconomic Studies

Limiting Iranian Nuclear Activities focuses on two basic questions. First, where is the appropriate place to draw the line between "limited enrichment"—defined as a situation where the world has a credible chance of responding to an Iranian attempt to rapidly build a bomb—and "robust enrichment," which Levi defines as a situation that would leave Iran able to build a bomb without being stopped? Second, what are the different international consequences of policies that leave Iran with limited enrichment, robust enrichment, or an actual weapons capability?

More on:

Iran

Nonproliferation, Arms Control, and Disarmament

Rather than recommending specific goals or red lines for U.S. policy, the paper focuses on illuminating the range of possible outcomes in order to better guide decisions on strategy.

More on:

Iran

Nonproliferation, Arms Control, and Disarmament

Top Stories on CFR

Israeli-Palestinian Conflict

An impending Israeli ground invasion of Rafah could threaten more than a million civilians seeking refuge in the city and further restrict humanitarian aid into the Gaza Strip.

Maldives

Once a close Indian partner, the Maldives is now aligning more with China. Is the island nation becoming a flash point in the China-India relationship? 

Public Health Threats and Pandemics

A global surge in avian flu outbreaks in birds and some mammals is worrying poultry farmers, scientists, and health experts. The trend is provoking questions about the future of the disease and global public health.